[
  {
    "title": "亚辉龙(688575.SH)：财务总监变更为廖立生",
    "href": "http://stock.jrj.com.cn/2022/12/30155837249664.shtml",
    "datetime": "2022-12-30 15:58:19",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：财务总监庞世洪完成减持30万股",
    "href": "http://stock.jrj.com.cn/2022/12/30155437249674.shtml",
    "datetime": "2022-12-30 15:54:55",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：子公司取得2项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/11/29182237175184.shtml",
    "datetime": "2022-11-29 18:22:35",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：硕丰长江3号私募增持完毕 已累计增持1.9836%股份",
    "href": "http://stock.jrj.com.cn/2022/11/22185737158394.shtml",
    "datetime": "2022-11-22 18:57:03",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新冠抗原检测产品被列入WHO应急使用清单",
    "href": "http://stock.jrj.com.cn/2022/11/03161437109746.shtml",
    "datetime": "2022-11-03 16:14:28",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：新冠抗原检测试剂盒(胶体金免疫层析法)被列入WHO应急使用清单",
    "href": "http://stock.jrj.com.cn/2022/11/03161337109762.shtml",
    "datetime": "2022-11-03 16:13:56",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：红土医疗以集中竞价共减持0.9707%的股份",
    "href": "http://stock.jrj.com.cn/2022/10/31155337099806.shtml",
    "datetime": "2022-10-31 15:53:10",
    "code": "688575"
  },
  {
    "title": "亚辉龙2022年前三季度预计净利8.6亿-8.8亿同比增加455%-468% 新冠产品业务销售增长",
    "href": "http://stock.jrj.com.cn/2022/10/20203237071303.shtml",
    "datetime": "2022-10-20 20:32:35",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)前三季度净利润预增455.02%-467.93%",
    "href": "http://stock.jrj.com.cn/2022/10/20155937069988.shtml",
    "datetime": "2022-10-20 15:59:29",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：控股子公司卓润生物拟增资并引入员工跟投平台",
    "href": "http://stock.jrj.com.cn/2022/09/29205937032218.shtml",
    "datetime": "2022-09-29 20:59:54",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：高管庞世洪减持期过半未减持",
    "href": "http://stock.jrj.com.cn/2022/09/29190737031860.shtml",
    "datetime": "2022-09-29 19:07:54",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575)：实际控制人的一致行动人增持公司股份进展",
    "href": "http://stock.jrj.com.cn/2022/09/01090736961421.shtml",
    "datetime": "2022-09-01 09:07:54",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：硕丰长江3号私募已累计增持1.01%股份",
    "href": "http://stock.jrj.com.cn/2022/08/31193836959335.shtml",
    "datetime": "2022-08-31 19:38:04",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：取得医疗器械注册证、为性激素结合球蛋白测定试剂盒(化学发光法)",
    "href": "http://stock.jrj.com.cn/2022/08/19174936916848.shtml",
    "datetime": "2022-08-19 17:49:50",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：硕丰长江3号私募证券投资基金累计增持479.65万股",
    "href": "http://stock.jrj.com.cn/2022/08/17163836908156.shtml",
    "datetime": "2022-08-17 16:38:52",
    "code": "688575"
  },
  {
    "title": "亚辉龙实控人的一致行动人拟增持1.5亿元-2.8亿元股份",
    "href": "http://stock.jrj.com.cn/2022/08/03173236867201.shtml",
    "datetime": "2022-08-03 17:32:57",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：实控人的一致行动人胡德明拟通过契约型基金增持1.5亿元-2.8亿元公司股份",
    "href": "http://stock.jrj.com.cn/2022/08/03171536867137.shtml",
    "datetime": "2022-08-03 17:15:24",
    "code": "688575"
  },
  {
    "title": "亚辉龙上半年净利润同比增长超6.5倍 聚焦新冠业务发展战略奏效",
    "href": "http://stock.jrj.com.cn/2022/07/29091136852627.shtml",
    "datetime": "2022-07-29 09:11:17",
    "code": "688575"
  },
  {
    "title": "亚辉龙披露2022年半年报：实现净利润6.66亿元",
    "href": "http://stock.jrj.com.cn/2022/07/21144436831816.shtml",
    "datetime": "2022-07-21 14:44:03",
    "code": "688575"
  },
  {
    "title": "亚辉龙：2022年上半年净利6.66亿，同比增长652%",
    "href": "http://stock.jrj.com.cn/2022/07/21103136831215.shtml",
    "datetime": "2022-07-21 10:31:30",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575)：2022年上半年营收增长326.46%，净利润增长651.7%",
    "href": "http://stock.jrj.com.cn/2022/07/21093236830994.shtml",
    "datetime": "2022-07-21 09:32:41",
    "code": "688575"
  },
  {
    "title": "亚辉龙2022年上半年净利6.66亿同比增长652% 产品销售大增",
    "href": "http://stock.jrj.com.cn/2022/07/20223136830098.shtml",
    "datetime": "2022-07-20 22:31:08",
    "code": "688575"
  },
  {
    "title": "亚辉龙拟在湘潭高新区投资建设湖南亚辉龙医疗器械产业园项目 总投资金额预计不超过6亿",
    "href": "http://stock.jrj.com.cn/2022/07/20223136830093.shtml",
    "datetime": "2022-07-20 22:31:05",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：拟增加“湖南亚辉龙医疗器械产业园项目”投资额",
    "href": "http://stock.jrj.com.cn/2022/07/20185536829467.shtml",
    "datetime": "2022-07-20 18:55:09",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)半年度净利润6.66亿元、同比增长651.70%",
    "href": "http://stock.jrj.com.cn/2022/07/20185236829468.shtml",
    "datetime": "2022-07-20 18:52:52",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：副董事长、总经理宋永波拟减持不超30万股",
    "href": "http://stock.jrj.com.cn/2022/07/20184836829434.shtml",
    "datetime": "2022-07-20 18:48:29",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：监事王慧翀近亲属短线交易及致歉",
    "href": "http://stock.jrj.com.cn/2022/07/08162536794662.shtml",
    "datetime": "2022-07-08 16:25:13",
    "code": "688575"
  },
  {
    "title": "亚辉龙：股东红土医疗拟减持不超1%公司股份",
    "href": "http://stock.jrj.com.cn/2022/07/01135036775075.shtml",
    "datetime": "2022-07-01 13:50:07",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：红土医疗拟减持不超567万股",
    "href": "http://stock.jrj.com.cn/2022/06/30182536772292.shtml",
    "datetime": "2022-06-30 18:25:09",
    "code": "688575"
  },
  {
    "title": "A股异动丨亚辉龙(688575.SH)跌约4% 部分高级管理人员拟集中竞价减持股份",
    "href": "http://stock.jrj.com.cn/2022/06/08102136711492.shtml",
    "datetime": "2022-06-08 10:21:40",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575)：部分高级管理人员集中竞价减持股份计划",
    "href": "http://stock.jrj.com.cn/2022/06/08091736711212.shtml",
    "datetime": "2022-06-08 09:17:03",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：深创投及其一致行动人的合计持股比例减少至5%",
    "href": "http://stock.jrj.com.cn/2022/06/07185036710064.shtml",
    "datetime": "2022-06-07 18:50:02",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：财务总监、董秘庞世洪拟减持不超30万股",
    "href": "http://stock.jrj.com.cn/2022/06/07184536710023.shtml",
    "datetime": "2022-06-07 18:45:12",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：2021年度权益分派10转4派4元 股权登记日为6月1日",
    "href": "http://stock.jrj.com.cn/2022/05/26175736681743.shtml",
    "datetime": "2022-05-26 17:57:44",
    "code": "688575"
  },
  {
    "title": "A股异动 | 亚辉龙(688575.SH)跌超9% 1.54亿股限售股今日解禁",
    "href": "http://stock.jrj.com.cn/2022/05/17141236654799.shtml",
    "datetime": "2022-05-17 14:12:10",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：1.54亿股限售股将于5月17日解禁上市",
    "href": "http://stock.jrj.com.cn/2022/05/09180136608361.shtml",
    "datetime": "2022-05-09 18:01:18",
    "code": "688575"
  },
  {
    "title": "云康集团(02325.HK)拟全球发售1.38亿股 引入Harvest及亚辉龙作为基石",
    "href": "http://stock.jrj.com.cn/2022/05/05062736564389.shtml",
    "datetime": "2022-05-05 06:27:55",
    "code": "688575"
  },
  {
    "title": "亚辉龙2021年净利2.05亿同比下滑2.75% 董事长胡鹍辉薪酬39.16万",
    "href": "http://stock.jrj.com.cn/2022/05/04141136555472.shtml",
    "datetime": "2022-05-04 14:11:39",
    "code": "688575"
  },
  {
    "title": "亚辉龙披露2021年年报 实现营收11.78亿元",
    "href": "http://stock.jrj.com.cn/2022/04/29085736500676.shtml",
    "datetime": "2022-04-29 08:57:11",
    "code": "688575"
  },
  {
    "title": "亚辉龙披露2022年一季报 实现营收13.70亿元",
    "href": "http://stock.jrj.com.cn/2022/04/29085536500678.shtml",
    "datetime": "2022-04-29 08:55:26",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：2021年净利降2.75%至2.05亿元 拟10转4派4元",
    "href": "http://stock.jrj.com.cn/2022/04/28180836494018.shtml",
    "datetime": "2022-04-28 18:08:57",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：一季度净利润增1257.79%至5.11亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28180536494025.shtml",
    "datetime": "2022-04-28 18:05:00",
    "code": "688575"
  },
  {
    "title": "亚辉龙2022年第一季度预计净利4.5亿-5亿 同比增加1095%-1228% 产品销售收入增长",
    "href": "http://stock.jrj.com.cn/2022/04/15101036341777.shtml",
    "datetime": "2022-04-15 10:10:40",
    "code": "688575"
  },
  {
    "title": "首季净利超去年全年两倍！新冠抗原检测试剂盒海外创收，亚辉龙一季度净利同比预增超10倍",
    "href": "http://stock.jrj.com.cn/2022/04/15084936341267.shtml",
    "datetime": "2022-04-15 08:49:20",
    "code": "688575"
  },
  {
    "title": "亚辉龙：预计一季度净利润同比增1094.75%至1227.5%",
    "href": "http://stock.jrj.com.cn/2022/04/14184136336515.shtml",
    "datetime": "2022-04-14 18:41:42",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：一季度净利润预增1094.75%-1227.50%",
    "href": "http://stock.jrj.com.cn/2022/04/14183536336507.shtml",
    "datetime": "2022-04-14 18:35:24",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：第二笔订单项下新冠病毒抗原检测试剂盒均已交付完毕",
    "href": "http://stock.jrj.com.cn/2022/03/28213435943998.shtml",
    "datetime": "2022-03-28 21:34:25",
    "code": "688575"
  },
  {
    "title": "亚辉龙累计已收到新型冠状病毒抗原检测试剂盒订单全部货款合计10294.17万美元",
    "href": "http://stock.jrj.com.cn/2022/03/28205235935508.shtml",
    "datetime": "2022-03-28 20:52:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：与MBL的新型冠状病毒抗原检测试剂盒合同第二笔订单已交付完毕",
    "href": "http://stock.jrj.com.cn/2022/03/28163735885949.shtml",
    "datetime": "2022-03-28 16:37:19",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035346364.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035356534.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035429407.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035450225.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035492667.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035621997.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035634801.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035647755.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035673778.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035699846.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035725581.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035749327.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035816975.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035853552.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175034920702.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035376847.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035548369.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035777280.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035791190.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035803758.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035407873.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035460771.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035471342.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035514537.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035525737.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035572083.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035584299.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035609288.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035686746.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035764831.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035865428.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035877546.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035366418.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035387275.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035397733.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035418078.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035439709.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035481959.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035503512.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035537153.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035560144.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035596677.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035660475.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035712888.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035738659.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035829326.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035841575.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获医疗器械注册证 有利于完善公司国内市场布局",
    "href": "http://stock.jrj.com.cn/2022/03/24175035888042.shtml",
    "datetime": "2022-03-24 17:50:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新冠病毒抗原检测试剂盒获国内医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/03/24154034897013.shtml",
    "datetime": "2022-03-24 15:40:29",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：新型冠状病毒(2019-nCoV)抗原检测试剂盒(胶体金法)获得国内医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/03/24153934896997.shtml",
    "datetime": "2022-03-24 15:39:26",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：公司新冠病毒抗原检测产品尚未取得国内药监部门颁发的注册证书",
    "href": "http://stock.jrj.com.cn/2022/03/11221734815987.shtml",
    "datetime": "2022-03-11 22:17:09",
    "code": "688575"
  },
  {
    "title": "A股异动 | 亚辉龙(688575.SH)跌8.94% 毛利率下降 增收不增利",
    "href": "http://stock.jrj.com.cn/2022/02/22105034433668.shtml",
    "datetime": "2022-02-22 10:50:42",
    "code": "688575"
  },
  {
    "title": "增收不增利！亚辉龙去年盈利微降0.94%",
    "href": "http://stock.jrj.com.cn/2022/02/21113834418748.shtml",
    "datetime": "2022-02-21 11:38:15",
    "code": "688575"
  },
  {
    "title": "亚辉龙2021年净利2.09亿同比下滑0.94% 销售费用增长较大",
    "href": "http://stock.jrj.com.cn/2022/02/18215034400416.shtml",
    "datetime": "2022-02-18 21:50:47",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2022/02/18185934395157.shtml",
    "datetime": "2022-02-18 18:59:24",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：MBL拟向公司增加采购约5000万美元的新型冠状病毒抗原检测试剂盒",
    "href": "http://stock.jrj.com.cn/2022/02/18185834395155.shtml",
    "datetime": "2022-02-18 18:58:27",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)业绩快报：2021年归母净利降0.94%至2.09亿元",
    "href": "http://stock.jrj.com.cn/2022/02/18185334395149.shtml",
    "datetime": "2022-02-18 18:53:16",
    "code": "688575"
  },
  {
    "title": "亚辉龙收到MBL发送的《Purchase Order》 金额价税合计为5294.17万美元",
    "href": "http://stock.jrj.com.cn/2022/02/14195234346062.shtml",
    "datetime": "2022-02-14 19:52:57",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：MBL拟向公司采购5294.17万美元新冠病毒抗原检测试剂盒",
    "href": "http://stock.jrj.com.cn/2022/02/13160534332156.shtml",
    "datetime": "2022-02-13 16:05:09",
    "code": "688575"
  },
  {
    "title": "亚辉龙：签订3.37亿元新冠病毒抗原检测试剂盒",
    "href": "http://stock.jrj.com.cn/2022/02/13155034332134.shtml",
    "datetime": "2022-02-13 15:50:48",
    "code": "688575"
  },
  {
    "title": "A股异动 | 亚辉龙(688575.SH)高开8% 新冠检测试剂盒获日本PMDA销售许可",
    "href": "http://stock.jrj.com.cn/2022/02/11093034320768.shtml",
    "datetime": "2022-02-11 09:30:47",
    "code": "688575"
  },
  {
    "title": "亚辉龙：新型冠状病毒抗原检测试剂盒获得日本PMDA认证指定供应",
    "href": "http://stock.jrj.com.cn/2022/02/10183334319061.shtml",
    "datetime": "2022-02-10 18:33:35",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：新型冠状病毒抗原检测试剂盒获得日本PMDA认证指定供应",
    "href": "http://stock.jrj.com.cn/2022/02/10183034319050.shtml",
    "datetime": "2022-02-10 18:30:43",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：向63名激励对象授予163.30万股限制性股票",
    "href": "http://stock.jrj.com.cn/2022/02/07185534302709.shtml",
    "datetime": "2022-02-07 18:55:08",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：拟向臻熙医学进行投资",
    "href": "http://stock.jrj.com.cn/2022/01/26200334224838.shtml",
    "datetime": "2022-01-26 20:03:25",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：拟推2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/01/14190134158770.shtml",
    "datetime": "2022-01-14 19:01:55",
    "code": "688575"
  },
  {
    "title": "A股异动 | 亚辉龙涨6% 全资子公司首次取得过敏原检测试剂注册证",
    "href": "http://stock.jrj.com.cn/2021/12/28103934075259.shtml",
    "datetime": "2021-12-28 10:39:58",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：取得吸入性及食物性过敏原特异性IgE抗体检测试剂盒(免疫印迹法)的医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/12/27173034071364.shtml",
    "datetime": "2021-12-27 17:30:41",
    "code": "688575"
  },
  {
    "title": "A股异动 | 亚辉龙涨5% 壳多糖酶3样蛋白1检测试剂盒取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/12/24095834056430.shtml",
    "datetime": "2021-12-24 09:58:47",
    "code": "688575"
  },
  {
    "title": "亚辉龙控股子公司取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/invest/2021/12/24093134056648.shtml",
    "datetime": "2021-12-24 09:31:00",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：壳多糖酶3样蛋白1检测试剂盒取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/12/23191134053817.shtml",
    "datetime": "2021-12-23 19:11:45",
    "code": "688575"
  },
  {
    "title": "亚辉龙：公司新冠抗原自测检测试剂盒获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2021/12/19170034032658.shtml",
    "datetime": "2021-12-19 17:00:35",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：全自动化学发光免疫分析仪(iFlash3000-M、iFlash3000-N)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/11/24191633915261.shtml",
    "datetime": "2021-11-24 19:16:18",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：171.7003万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/11/08201733824340.shtml",
    "datetime": "2021-11-08 20:17:52",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：取得IVDR CE认证 共包括14个产品",
    "href": "http://stock.jrj.com.cn/2021/10/22180333734567.shtml",
    "datetime": "2021-10-22 18:03:46",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：取得12项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/09/01185633368981.shtml",
    "datetime": "2021-09-01 18:56:59",
    "code": "688575"
  },
  {
    "title": "国产替代的蓝海市场，后疫情时代的亚辉龙（688575.SH）回归主业显高成长性",
    "href": "http://stock.jrj.com.cn/2021/08/28165133339447.shtml",
    "datetime": "2021-08-28 16:51:44",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)半年度净利润8856.16万元 同比下降12.05%",
    "href": "http://stock.jrj.com.cn/2021/08/27221633336532.shtml",
    "datetime": "2021-08-27 22:16:55",
    "code": "688575"
  },
  {
    "title": "亚辉龙2021年半年度净利8856.16万元 同比净利减少12.05%",
    "href": "http://stock.jrj.com.cn/2021/08/27220133336407.shtml",
    "datetime": "2021-08-27 22:01:03",
    "code": "688575"
  },
  {
    "title": "亚辉龙：公司目前经营正常 仪器装机、终端仪器测试上量工作持续推进中",
    "href": "http://stock.jrj.com.cn/2021/06/15084432932354.shtml",
    "datetime": "2021-06-15 08:44:43",
    "code": "688575"
  },
  {
    "title": "今日上市：睿昂基因、亚辉龙",
    "href": "http://stock.jrj.com.cn/2021/05/17090332767395.shtml",
    "datetime": "2021-05-17 09:03:00",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575)：将于5月17日在上海证券交易所科创板上市",
    "href": "http://stock.jrj.com.cn/2021/05/14100832753883.shtml",
    "datetime": "2021-05-14 10:08:16",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)：公司股票将于5月17日起上市交易",
    "href": "http://stock.jrj.com.cn/2021/05/13200332750219.shtml",
    "datetime": "2021-05-13 20:03:01",
    "code": "688575"
  },
  {
    "title": "亚辉龙(688575.SH)披露上市发行结果：遭弃购8782股 由主承销商包销",
    "href": "http://stock.jrj.com.cn/2021/05/11192532736805.shtml",
    "datetime": "2021-05-11 19:25:41",
    "code": "688575"
  },
  {
    "title": "交易真实性被质疑、财务前后披露不一致吃罚单 亚辉龙提交注册半年未拿到批文",
    "href": "http://stock.jrj.com.cn/2021/03/09095932096329.shtml",
    "datetime": "2021-03-09 09:59:31",
    "code": "688575"
  },
  {
    "title": "亚辉龙将登科创板：利润翻倍增长 体外诊断行业加速资本化",
    "href": "http://stock.jrj.com.cn/kcb/2020/09/24073330822238.shtml",
    "datetime": "2020-09-24 07:33:35",
    "code": "688575"
  },
  {
    "title": "“自产”取代“代理”驱动盈利增长 体外诊断产品供应商亚辉龙募资7.33亿元将赴科创板IPO | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/09/01184230654587.shtml",
    "datetime": "2020-09-01 18:42:54",
    "code": "688575"
  },
  {
    "title": "亚辉龙过会:今年科创板过会第105家 中信证券过14.5单",
    "href": "http://stock.jrj.com.cn/2020/08/31115330642271.shtml",
    "datetime": "2020-08-31 11:53:00",
    "code": "688575"
  },
  {
    "title": "汉弘集团、亚辉龙8月28日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/08/27085930601662.shtml",
    "datetime": "2020-08-27 08:59:00",
    "code": "688575"
  },
  {
    "title": "汉弘集团、亚辉龙8月25日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/08/17111230516623.shtml",
    "datetime": "2020-08-17 11:12:00",
    "code": "688575"
  },
  {
    "title": "新冠病毒检测试剂盒厂商亚辉龙拟赴科创板上市",
    "href": "http://stock.jrj.com.cn/kcb/2020/04/08200729239190.shtml",
    "datetime": "2020-04-08 20:07:56",
    "code": "688575"
  }
]